Sun L - Search Results

1

[Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression].

Guo J, Mu D, Yu W, Sun L, Zhang J, Ren X, Han Y. Guo J, et al. Among authors: sun l. Zhongguo Fei Ai Za Zhi. 2023 Feb 20;26(2):105-112. doi: 10.3779/j.issn.1009-3419.2023.106.04. Zhongguo Fei Ai Za Zhi. 2023. PMID: 36872049 Free PMC article. Chinese.

2

[Expression of coxsackievirus and adenovirus receptor in non-small cell lung cancer and its significance].

Gu AK, Sun LN, Chen ZL, Zhan ZL, Li JW. Gu AK, et al. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):278-81. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615283 Chinese.

3

[Relationship between EGFR and K-ras mutations and clinicopathological characteristics and response to erlotinib treatment in 301 Chinese patients with non-small cell lung cancer].

Sun LN, Luan HL, Zang FL, Wang M, Dong N, Guo Y, Sun BC, Zhan ZL. Sun LN, et al. Zhonghua Zhong Liu Za Zhi. 2010 Sep;32(9):667-70. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21122380 Chinese.

4

Platelet-lymphocyte ratio is an independent prognostic factor in patients with ALK-positive non-small-cell lung cancer.

Han Y, Wang J, Hong L, Sun L, Zhuang H, Sun B, Wang H, Zhang X, Ren X. Han Y, et al. Among authors: sun l, sun b. Future Oncol. 2017 Jan;13(1):51-61. doi: 10.2217/fon-2016-0317. Epub 2016 Aug 15. Future Oncol. 2017. PMID: 27523323

5

Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation.

Zhang Q, Zhang B, Sun L, Yan Q, Zhang Y, Zhang Z, Su Y, Wang C. Zhang Q, et al. Among authors: sun l. Acta Biochim Biophys Sin (Shanghai). 2018 Aug 1;50(8):748-756. doi: 10.1093/abbs/gmy074. Acta Biochim Biophys Sin (Shanghai). 2018. PMID: 29961813 Free article.

6

METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m⁶A/c-Myc-dependent aerobic glycolysis.

Zhang Q, Zhang Y, Chen H, Sun LN, Zhang B, Yue DS, Wang CL, Zhang ZF. Zhang Q, et al. Cell Cycle. 2022 Dec;21(24):2602-2614. doi: 10.1080/15384101.2022.2105885. Epub 2022 Aug 16. Cell Cycle. 2022. PMID: 35972892 Free PMC article.

7

Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer.

Sun X, Liu W, Sun L, Mo H, Feng Y, Wu X, Li C, Chen C, Li J, Xin Y, Zhang Z, Wang C, Zhang B, Yue D. Sun X, et al. Among authors: sun l. J Immunother Cancer. 2022 Nov;10(11):e005531. doi: 10.1136/jitc-2022-005531. J Immunother Cancer. 2022. PMID: 37011953 Free PMC article.

8

Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice.

Sun L, Zhang Q, Luan H, Zhan Z, Wang C, Sun B. Sun L, et al. Among authors: sun b. J Exp Clin Cancer Res. 2011 Mar 17;30(1):30. doi: 10.1186/1756-9966-30-30. J Exp Clin Cancer Res. 2011. PMID: 21414214 Free PMC article.

9

Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma.

Jiang R, Jin Z, Liu Z, Sun L, Wang L, Li K. Jiang R, et al. Among authors: sun l. Mol Diagn Ther. 2011 Dec 1;15(6):347-52. doi: 10.1007/BF03256470. Mol Diagn Ther. 2011. PMID: 22208386

10

T1aN0M0 and T1bN0M0 non-small cell lung cancer: a retrospective study of the prognosis.

Zhang Z, Wang A, Zhan Z, Sun L, Chen K, Wang C. Zhang Z, et al. Among authors: sun l. Thorac Cardiovasc Surg. 2014 Mar;62(2):109-16. doi: 10.1055/s-0032-1329191. Epub 2012 Dec 6. Thorac Cardiovasc Surg. 2014. PMID: 23225513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,275 results

Search Page

Filters